180+ networks across 21 NJ counties
COMMUNITY ENGAGEMENT CORE OVERVIEW
NJACTS draws leading academic, industry and community groups together to understand and address the health needs of New Jersey. Central to this is engagement with our community to ensure that our efforts respond to their priorities. Our goal is to conduct research with the New Jersey community, in the community and for the community, and yet, have impact beyond our state’s boundaries.
Stay in Touch!
Join RCommunity!
Join Rutgers Health Service Corps!
Empowering Community-Based Research
Through Cultural and Linguistic Collaboration
- Navigating interpreter-mediated encounters
- Effective translation for research
- Understanding cultural nuances in literacy, trust, and belonging
Through collaboration across disciplines and leveraging expertise within and beyond Rutgers, CrEER ensures that research is culturally relevant and impactful both locally and globally.
👉 Discover how CrEER is shaping the future of community-based research here.
Association for Clinical and Translational Science (ATCS) Membership for Community Members
Did you know that community members are eligible to become members of ACTS through their affiliation with NJ ACTS?
Community members are able to access ACTS’ member benefits, including:
- Discounted registration to the annual Translational Science meeting
- Opportunities to participate in Special Interest Groups and Committees
- Access to the community platform website and more!
Resource for Investigators – CTSA Compendium of D&I Catalogs
Dissemination and implementation (D&I) research focuses on translating evidence-based interventions into real-world settings to improve health outcomes in the broader community.
An open-source CTSA Compendium of D&I Catalogs has been developed by the Clinical & Translational Science Awards (CTSA) Program’s “Advancing Dissemination and Implementation Sciences in CTSAs” working group to support investigators at any stage of their D&I skill-building journey. It provides a curated list of resource catalogs relevant to the conduct of D&I science. The materials include frameworks/theories/models, methods/measures, funding resources, and practice and training resources.
Click here to learn more.
CIRTification – A New Alternative to CITI for Community Partners
The rollout of CIRTification at Rutgers has begun. The CIRTification program provides research ethics training alternatives for individuals in community organizations, with limited understanding of conducting human research and protecting potential research participants. This option provides training focused on equipping community partners to conduct human subject research effectively and safely in their communities.
To learn more about the program at Rutgers, please visit this link CIRTification.
NJ ACTS COMMUNITY SCIENTIST PROGRAM
This program is designed to provide researchers with rapid feedback from expert community members to ensure their research projects are culturally appropriate and relevant to the community.
PARTICIPATE IN OUR NEXT COHORT!
For more information, please contact njactscommunity@rwjms.rutgers.edu
NJ HEROES TOO
Through the ongoing New Jersey Healthcare Essential Worker Outreach and Education Study – Testing Overlooked Occupations (NJ HEROES TOO), we have gained a wealth of data on COVID-19’s effects, gleaned valuable learnings on attitudes toward testing and vaccines, and improved COVID-19 awareness in underserved communities.
Community Blog
New Jersey bucked U.S. trend in drug overdoses last year, but 2021 could be the deadliest.
New Jersey may have been an outlier when the United States surpassed 100,000 drug overdose deaths last year, but the Garden State is now on a path toward its own somber milestone in a decade-long epidemic. Preliminary data shows New Jersey is on pace to end 2021 with...
Apply for a 2022 Global Health Institute Seed Grant
Rutgers Global Health Institute awards Global Health Seed Grants to faculty conducting collaborative, interdisciplinary activities that address health inequities in New Jersey and around the world. With these grants, we aim to help faculty pursue new ideas and seed...
Merck’s Covid-19 Pill Backed by FDA Advisers
An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck MRK -0.74% & Co. and partner Ridgeback Biotherapeutics LP. The panel, known as the...
Power and Participation: How Community Health Centers Address the Determinants of the Social Determinants of Health
NEJM Catalyst Innovations in Care Delivery The health inequities revealed by the Covid-19 pandemic, along with heightened awareness of racial justice issues, present opportunities for leaders, especially at community-based health centers, to engage with, listen to,...
Rutgers–Camden Researcher Explains Omicron Variant’s Impact on the Stock Market.
With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility...
How to deal with (even more) COVID-19 uncertainty
If you’re struggling to “wait and see” how bad omicron might be, here are productive ways to cope. Read the Full Article.